Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections
Biofilm Formation Increases Treatment Failure in Staphylococcus Epidermidis Device-related Osteomyelitis in Human Patients
1 other identifier
observational
124
1 country
1
Brief Summary
This was a prospective study performed between November 2011 and September 2013. Patients with a confirmed S. epidermidis infection after fracture fixation or prosthetic joint infection were included. Exclusion criteria included infections involving external fixation pins, infections without any implanted hardware and culture positive patients not displaying any clinical sign of infection. The following surgical parameters were documented: affected bone or joint; type of implant; time between implantation of the device and onset of symptoms. Personal characteristics and patients'health status were also documented. Any revision surgeries involving the site of interest and all isolated pathogens were recorded throughout the course of treatment and follow-up. A follow up examination was performed an average of 26 months after discharge. Primary outcome at follow up was cure. Cure was define by the authors as: missing local (at site of interest) or systemic signs of infection, terminated surgical and systemic therapy and restoration of joint or limb function. At the first surgical procedure after enrolment, at least four deep bone biopsies were taken from the interface between implant and affected bone. Identification and antibiotic susceptibility testing of all growth was performed. Multi-drug-resistance (MDR) was defined according to the definitions of the European Committee of Antimicrobial Susceptibility Testing (EUCAST). Biofilm formation was analysed and quantified in microtitre plate assays according to protocol of Stepanovic et al.(see references).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 16, 2015
CompletedFirst Posted
Study publicly available on registry
December 29, 2015
CompletedDecember 29, 2015
December 1, 2015
3.8 years
December 16, 2015
December 22, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cure
Cure was define by the authors as: missing local (at site of interest) or systemic signs of infection and terminated surgical and systemic antibiotic therapy. All Parameters had to be positive to fulfill the outcome parameter "cure".If one of the mentioned parameters was negative, outcome was defined as "not cured". Local signs of infection were defined as the appearance of: redness, tenderness, swelling or persisting wound drainage.
24 month
Study Arms (1)
Orthopaedic device related infections
Inclusion Criteria: * infections after fracture fixation or prosthetic joint surgery * Affected bone or joint: Long bones of the lower extremity; hip joint, knee joint; * Bacterial growth of S. epidermidis at the site of interest * Written consent * Age: 18 and older
Eligibility Criteria
Orthopaedic device related infection involving longbones of the lower extermity
You may qualify if:
- infections after fracture fixation or prosthetic joint surgery
- Affected bone or joint: Long bones of the lower extremity; hip joint, knee joint;
- Bacterial growth of S. epidermidis at the site of interest
- Written consent
- Age: 18 and older
You may not qualify if:
- no prove of bacterial growth at site of interest
- missing consent
- infections involving external fixation pins, infections without any implanted hardware.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BG Unfallklinik Murnau
Murnau am Staffelsee, Bavaria, 82418, Germany
Related Publications (2)
Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I, Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007 Aug;115(8):891-9. doi: 10.1111/j.1600-0463.2007.apm_630.x.
PMID: 17696944BACKGROUNDPost V, Harris LG, Morgenstern M, Mageiros L, Hitchings MD, Meric G, Pascoe B, Sheppard SK, Richards RG, Moriarty TF. Comparative Genomics Study of Staphylococcus epidermidis Isolates from Orthopedic-Device-Related Infections Correlated with Patient Outcome. J Clin Microbiol. 2017 Oct;55(10):3089-3103. doi: 10.1128/JCM.00881-17. Epub 2017 Aug 9.
PMID: 28794175DERIVED
Biospecimen
Bacterial samples from orthopaedic device realted infections
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mario Morgenstern, M.D.
BGUnfallklinik Murnau
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in Orthopedic Surgery
Study Record Dates
First Submitted
December 16, 2015
First Posted
December 29, 2015
Study Start
November 1, 2011
Primary Completion
September 1, 2015
Study Completion
November 1, 2015
Last Updated
December 29, 2015
Record last verified: 2015-12